Drugs / Nitric Oxide-Releasing Solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04755647 | Feb 2021 → May 2023 | ulcer of lower limbs | Sanotize Research and Development corp. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nitric Oxide-Releasing Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04755647 ↗ |
| Known as | NORS | “Nitric Oxide-Releasing Solution (NORS)” NCT04755647 ↗ |
| Route | Topical | “Topical Nitric Oxide Releasing Solution” NCT04755647 ↗ |